The role of a protein called XIAP in the regulation of cell death has been identified by researchers and has led them to recommend caution when drugs called IAP inhibitors are used to treat cancer patients with underlying liver conditions.
The role of a protein called XIAP in the regulation of cell death has been identified by researchers and has led them to recommend caution when drugs called IAP inhibitors are used to treat cancer patients with underlying liver conditions.